Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery

[1]  W. Kostis,et al.  Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis). , 2017, The American journal of cardiology.

[2]  A. Kulik.  Secondary prevention after coronary artery bypass graft surgery: a primer , 2016, Current opinion in cardiology.

[3]  D. Dudek,et al.  Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study. , 2015, American heart journal.

[4]  M. Hackett,et al.  Predictors associated with stroke after coronary artery bypass grafting: A systematic review , 2015, Journal of the Neurological Sciences.

[5]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[6]  V. Roger,et al.  Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. , 2015, Circulation.

[7]  E. Steyerberg,et al.  Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization with Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the SYNTAX Trial at 5-Year Follow-Up , 2015 .

[8]  S. Rezkalla,et al.  Outcome of early revascularization surgery in patients with ST-elevation myocardial infarction. , 2015, Journal of interventional cardiology.

[9]  T. Jernberg,et al.  Incidence, Trends, and Predictors of Ischemic Stroke 1 Year After an Acute Myocardial Infarction , 2014, Stroke.

[10]  T. Jernberg,et al.  Incidence, Trends, and Predictors of Ischemic Stroke 30 Days After an Acute Myocardial Infarction , 2014, Stroke.

[11]  T. Mooe,et al.  The Risk of Ischemic Stroke after an Acute Myocardial Infarction in Patients with Decreased Renal Function , 2014, Cerebrovascular Diseases.

[12]  E. Tuzcu,et al.  Late Stroke: Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Multivessel Disease and Unprotected Left Main Disease A Meta-Analysis and Review of Literature , 2014, Stroke.

[13]  T. Jernberg,et al.  Risk of Ischemic Stroke After an Acute Myocardial Infarction in Patients With Diabetes Mellitus , 2014, Circulation. Cardiovascular quality and outcomes.

[14]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[16]  C. Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[17]  E. Blackstone,et al.  Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. , 2011, JAMA.

[18]  E. Ohman,et al.  Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.

[19]  L. Wallentin,et al.  Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .

[20]  J. Alpert,et al.  Universal definition of myocardial infarction. , 2007, European heart journal.

[21]  S. Yusuf,et al.  Stroke in Relation to Cardiac Procedures in Patients With Non–ST-Elevation Acute Coronary Syndrome: A Study Involving >18 000 Patients , 2001, Circulation.

[22]  G. Dangas,et al.  Stroke After Coronary Artery Bypass: Incidence, Predictors, and Clinical Outcome , 2001, Stroke.

[23]  L. Wallentin,et al.  Early statin treatment following acute myocardial infarction and 1-year survival. , 2001, JAMA.

[24]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[25]  B. Stegmayr,et al.  Ischemic stroke. Impact of a recent myocardial infarction. , 1999, Stroke.

[26]  M. Moulton,et al.  Revascularization after acute myocardial infarction. , 1995, The Annals of thoracic surgery.

[27]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[28]  R. Adams,et al.  Coronary artery disease, myocardial infarction, and brain embolism. , 1993, Neurologic clinics.

[29]  P. Smith.  Long-term anticoagulant treatment after acute myocardial infarction. The Warfarin Re-Infarction Study. , 1992, Annals of epidemiology.

[30]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[31]  J. Folts,et al.  Epinephrine potentiation of in viw stimuli reverses aspirin inhibition of platelet thrombos formation in stenosed canine coronary arteries , 1988 .

[32]  J. T. ten Cate,et al.  Effects of extradural bupivacaine on the haemostatic system. , 1986, British Journal of Anaesthesia.

[33]  Kenneth W. Duckett,et al.  PLASMA-FIBRINOGEN AND THROMBOEMBOLI AFTER MYOCARDIAL INFARCTION , 1976, The Lancet.

[34]  J. Dunning,et al.  2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  J. Folts,et al.  Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries. , 1988, Thrombosis research.

[36]  E. Loeliger,et al.  Long-term anticoagulant treatment after acute myocardial infarction. , 1987, Advances in experimental medicine and biology.

[37]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .